These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17827541)

  • 1. Adenoviral vectors for gene therapy.
    Douglas JT
    Mol Biotechnol; 2007 May; 36(1):71-80. PubMed ID: 17827541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted adenoviral vectors.
    Barnett BG; Crews CJ; Douglas JT
    Biochim Biophys Acta; 2002 May; 1575(1-3):1-14. PubMed ID: 12020813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in gene therapy: averting the immune response to adenoviral vectors.
    Ritter T; Lehmann M; Volk HD
    BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer to brain and spinal cord using recombinant adenoviral vectors.
    Alisky JM; Davidson BL
    Methods Mol Biol; 2004; 246():91-120. PubMed ID: 14970587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.
    Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A
    Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the immune response to permit ex vivo gene therapy for spine fusion with human type 5 adenoviral delivery of the LIM mineralization protein-1 cDNA.
    Kim HS; Viggeswarapu M; Boden SD; Liu Y; Hair GA; Louis-Ugbo J; Murakami H; Minamide A; Suh DY; Titus L
    Spine (Phila Pa 1976); 2003 Feb; 28(3):219-26. PubMed ID: 12567021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.
    Lewis TB; Glasgow JN; Glandon AM; Curiel DT; Standaert DG
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model.
    Tang Y; Han T; Everts M; Zhu ZB; Gillespie GY; Curiel DT; Wu H
    Gene Ther; 2007 Mar; 14(6):523-32. PubMed ID: 17167498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus.
    Zhu J; Huang X; Yang Y
    J Immunol; 2010 Dec; 185(12):7480-6. PubMed ID: 21076062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus as an integrating vector.
    Mitani K; Kubo S
    Curr Gene Ther; 2002 May; 2(2):135-44. PubMed ID: 12109211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.
    Kibbe MR; Murdock A; Wickham T; Lizonova A; Kovesdi I; Nie S; Shears L; Billiar TR; Tzeng E
    Arch Surg; 2000 Feb; 135(2):191-7. PubMed ID: 10668880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers.
    Cho YS; Do MH; Kwon SY; Moon C; Kim K; Lee K; Lee SJ; Hemmi S; Joo YE; Kim MS; Jung C
    Oncotarget; 2016 Jun; 7(25):38210-38223. PubMed ID: 27203670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35.
    Sakurai F
    Biol Pharm Bull; 2008 Oct; 31(10):1819-25. PubMed ID: 18827334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors.
    French BA; Mazur W; Geske RS; Bolli R
    Circulation; 1994 Nov; 90(5):2414-24. PubMed ID: 7525108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism.
    Alberti MO; Deshane JS; Chaplin DD; Pereboeva L; Curiel DT; Roth JC
    Gene Ther; 2013 Jul; 20(7):733-41. PubMed ID: 23171918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors.
    Douglas JT; Curiel DT
    Neuromuscul Disord; 1997 Jul; 7(5):284-98. PubMed ID: 9267842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells.
    Cheng C; Gall JG; Kong WP; Sheets RL; Gomez PL; King CR; Nabel GJ
    PLoS Pathog; 2007 Feb; 3(2):e25. PubMed ID: 17319743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of adenovirus serotype 35 as a gene transfer vector.
    Seshidhar Reddy P; Ganesh S; Limbach MP; Brann T; Pinkstaff A; Kaloss M; Kaleko M; Connelly S
    Virology; 2003 Jul; 311(2):384-93. PubMed ID: 12842627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.